SAFETY AND TOLERABILITY OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTEGRATED INTERIM ANALYSIS OF INFECTION RISK AND HEMATOLOGICAL CHANGES

被引：0
|
作者：
Muppidi, Srikanth
Pasnoor, Mamatha
Gelinas, Deborah
Brauer, Edward
Kerstens, Rene
Bhavaraju-Sanka, Ratna
Howard, James
机构：
来源：
MUSCLE & NERVE | 2022年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
193
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [31] Individualized Dosing of Efgartigimod in Patients With Generalized Myasthenia Gravis: Clinical Experience at a Single Center
    Silvestri, Nicholas J.
    MUSCLE & NERVE, 2025, 71 (03) : 422 - 428
  • [32] A Real-life experience with Eculizumab and Efgartigimod in generalized Myasthenia Gravis patients.
    Sacca, F.
    Pane, C.
    Espinosa, P.
    Sormani, M.
    Signori, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 569 - 570
  • [33] REAL-WORLD EXPERIENCE WITH INDIVIDUALIZED DOSING OF EFGARTIGIMOD IN PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS
    Silvestri, Nicholas
    MUSCLE & NERVE, 2024, 70 (03) : 638 - 638
  • [34] Efgartigimod Demonstrates Consistent Improvements in Generalized Myasthenia Gravis Patients of Shorter Disease Duration
    Bril, Vera
    Vu, Tuan
    Brauer, Edward
    Kerstens, Rene
    Howard, James
    NEUROLOGY, 2023, 100 (17)
  • [35] Tolerability and Safety of Plasma Exchange Therapy in Patients with Myasthenia Gravis
    Ebadi, Hamid
    Barth, David
    Bril, Vera
    NEUROLOGY, 2013, 80
  • [36] Mycophenolate mofetil for myasthenia gravis - An analysis of efficacy, safety, and tolerability
    Meriggioli, MN
    Ciafaloni, E
    Al-Hayk, KA
    Rowin, J
    Tucker-Lipscomb, B
    Massey, JM
    Sanders, DB
    NEUROLOGY, 2003, 61 (10) : 1438 - 1440
  • [37] Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis
    Antozzi, Carlo
    Guptill, Jeffrey
    Bril, Vera
    Gamez, Josep
    Meuth, Sven G.
    Nowak, Richard J.
    Quan, Dianna
    Sevilla, Teresa
    Jouvin, Marie-Helene
    Jin, Jim
    Karcher, Keith
    Ramchandren, Sindhu
    Sun, Hong
    Ling, Leona
    Zhu, Yaowei
    Arroyo, Santiago
    NEUROLOGY, 2024, 102 (02)
  • [38] Safety and outcomes with efgartigimod use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice
    Katyal, Nakul
    Halldorsdottir, Karen
    Govindarajan, Raghav
    Shieh, Perry
    Muley, Suraj
    Reyes, Phoebedel
    Leung, Kenneth K.
    Mullen, Jeffrey
    Milani-Nejad, Shadi
    Korb, Manisha
    Goyal, Namita A.
    Mozaffar, Tahseen
    Goyal, Neelam
    Habib, Ali A.
    Muppidi, Srikanth
    MUSCLE & NERVE, 2023, 68 (05) : 762 - 766
  • [39] Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial
    Howard, James F. Jr Jr
    Bril, Vera
    Vu, Tuan
    Karam, Chafic
    Perk, Stojan
    Margania, Temur
    Murai, Hiroyuki
    Bilinska, Malgorzata
    Shakarishvili, Roman
    Smilowski, Marek
    Guglietta, Antonio
    Ulrichts, Peter
    Vangeneugden, Tony
    Utsugisawa, Kimiaki
    Verschuuren, Jan
    Mantegazza, Renato
    LANCET NEUROLOGY, 2021, 20 (07): : 526 - 536
  • [40] Efgartigimod demonstrates consistent improvements in patients with generalized myasthenia gravis regardless of prior treatment failures
    Siddiqi, Zaeem
    Rozsa, Csilla
    Sacca, Francesco
    De Bleecker, Jan L.
    Verschuuren, Jan
    Hoffmann, Sarah
    Vu, Tuan
    Bril, Vera
    Murai, Hiroyuki
    Brauer, Edward
    Kerstens, Rene
    Steeland, Sophie
    Ulrichts, Peter
    Goyal, Neelam
    Vissing, John
    Mantegazza, Renato
    Howard, James F., Jr.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
12345